{"name":"Sabine Mueller, MD, PhD","slug":"sabine-mueller-md-phd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQbHE4MkZxd0dBVldmM01lWDZFRGhEYnNEWlJ5QmJBQmhmVk9VSm1rRjNZRFl5TkJ6cjBoaFdxTTMwR0tfOWpVY1dscjhFa0xMc0MzcUY0amV0Sk01SmEtM24yZnNiYXR3Z2RpOWtaTWZOczlsdE9jNjRLZ1RaYmxtM3VQX2pTVTA?oc=5","date":"2025-03-25","type":"pipeline","source":"MedPage Today","summary":"Pediatric Low-Grade Glioma: Defining the Disease and Its Long-Term Impact - MedPage Today","headline":"Pediatric Low-Grade Glioma: Defining the Disease and Its Long-Term Impact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOSGVCQnFqMUxteTc0Mk9CYmo1NDV5QWhVc2xjUnZFS3p1QmRBSUg4eVFObFZ6Wmc4bmpRNUIyenFvLXJiNXpJdEpWY1lvOC1RR3BzeDBtVFpOeFdIcmlacjJRZEdfUDk3Nko5OENoMFZqcDkya09vMkNRbzZsWUNlcloyTDJrUW9zUXludkpzXzBhYi1uWHpCX0VCN0M4WFZYZ0MzaDJVMlU0b09HT1BvUHk4c281WV9uUm0wbUdPd2p0X1Mwc2N0M1pMSWdITzJIMkE?oc=5","date":"2024-04-24","type":"regulatory","source":"Pharmaceutical Executive","summary":"FDA Grants Accelerated Approval to Day One’s Ojemda for Relapsed or Refractory Pediatric Low-Grade Glioma - Pharmaceutical Executive","headline":"FDA Grants Accelerated Approval to Day One’s Ojemda for Relapsed or Refractory Pediatric Low-Grade Glioma","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}